Drug profile · INN
ramelteon
ROZEREM
ramelteon (ROZEREM) is a melatonin receptor agonist. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Drug details — ramelteon
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 33
- Data quality
- 0.89
Quick answer
ramelteon (ROZEREM) is a melatonin receptor agonist. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Melatonin receptor agonist
Primary target: Melatonin receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| PMDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is ramelteon?
ramelteon (ROZEREM) is a melatonin receptor agonist. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ramelteon?
ROZEREM is a marketed brand name for ramelteon. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ramelteon?
ramelteon has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.